KARCLKardemir Celik Sanayi AS

🇹🇷 BİST
42.34
TRY
Analysis Scores
Lothien Robustness Score?
-
Neden bu skor?
Damodaran ?
-
Dalio Risk ?
-
Piotroski ?
-
Bilanço dosyası bulunamadı
Graham ?
-
Bilanço dosyası bulunamadı
Lothien Robustness Summary
57/100
Lothien Sağlamlık: Orta (57/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 5 | Negatif: 4 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte ₺375M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+965.3 arttı (₺35M → ₺375M). Kısa vadede olumlu momentum.
Yıllık Kâr Geriledi
Geçen yılın aynı dönemine göre net kâr %-41.9 düştü. Uzun vadede endişe verici.
3 Çeyrek Üst Üste Artış
Son 3 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+49.1 arttı. Şirket büyüyor.
Orta Seviye Borç
Net borç/özkaynak 1.22x. Yönetilebilir seviyede ama takip edilmeli.
Kârlı ama Nakit Üretemiyor
Net kâr pozitif (₺375M) ama FCF negatif (-₺36M). Yatırım harcamaları yüksek veya alacak birikimi var.
Yüksek F/K Uyarısı
Trailing F/K: 51.9. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Reel Kâr Büyümesi Var
Enflasyon düzeltmesi sonrası reel net kâr %+895.5 arttı (2026/6 çeyreği). Gerçek anlamda büyüyor.
Mevsimsel Toparlanma, Ama Trend Bozuk
Çeyreklik artış (%+965.3) ama yıllık bazda düşüş (%-41.9). Mevsimsel toparlanma var ama uzun vadeli trend zayıf.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-81.2 düşebilir. Sonraki bilançoya dikkat.

Data date date not measured Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date date not measured
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Valuation
Potential?
-
Balance Sheet Analysis? Q2026/6
Net kâr çeyreklik %+965.3 artarak 375.2M TL oldu
Yıllık net kâr %-41.9 geriledi
Hasılat çeyreklik %+10.4 büyüdü (7.3B TL)
Yıllık hasılat büyümesi güçlü (%+49.1)
Brüt kâr marjı düşük: %12.1
Net kâr marjı: %5.1
FAVÖK yatay seyrede (886.8M TL)
FAVÖK marjı: %12.1
Toplam borç: 13.9B TL
Net borç hasılatın üzerinde: 13.8B TL
Borç/Özkaynak oranı: 1.23x
Cari oran < 1: 1.00x — likidite riski
Nakit %+58.8 arttı → 73.3M TL
İşletme nakit akışı negatif: -1.0B TL
Serbest nakit akışı negatif: -36.1M TL — yatırımlar nakdi aşıyor
ROE düşük: %3.3
ROA düşük: %1.2
Toplam varlıklar: 32.3B TL (%+4.7)
Özkaynak: 11.3B TL (%-3.4)
İşletme kârı pozitif: 724.0M TL
İşletme kârı büyüme: %+43.1
Ödenmiş sermaye: 720.0M TL
Net işletme sermayesi negatif: -37.2M TL — kısa vadeli baskı
İşletme sermayesi değişimi: %+92.0
CAPEX: 1.0B TL (Hasılatın %13.9'i)
Son 3 çeyrek ardışık kâr
Fiyat TRAMA-99 hafif altında: %+0.0
Direnç seviyesi: TRAMA-99 = 42.34 TL
Inflation Adjusted Data?

Last month in the CPI series: 2026-07, and the series is not up to date; real values are stated in 2026/6 prices.

Real net profit +895.5% (inflation-adjusted) — genuine growth
Real equity eroded 26% over last 8 quarters — value loss vs inflation
Yıllık %32 enflasyona rağmen reel büyüme devam ediyor
Quarter CPI YoY Deflator Nominal Net Profit Real Net Profit Real Growth Nominal Revenue Real Revenue Reel ROE
2026/6 %32 ×1.00 ₺375M ₺375M %+895.5 ₺7.3B ₺7.3B %13.3
2026/3 %31 ×1.07 ₺35M ₺38M %-96.9 ₺6.6B ₺7.1B %1.2
2025/12 %31 ×1.18 ₺1.0B ₺1.2B %+15.7 ₺23.0B ₺27.1B %39.8
2025/9 %33 ×1.23 ₺-856M ₺-1.1B %-223.3 ₺-11.0B ₺-13.5B —
2025/6 %35 ×1.32 ₺646M ₺853M %+190.0 ₺4.9B ₺6.5B —
2025/3 %38 ×1.40 ₺210M ₺294M — ₺6.1B ₺8.6B —
2024/12 %44 ×1.54 — — — — — —
2023/12 %65 ×2.23 ₺1.4B ₺3.2B — ₺12.7B ₺28.4B %84.2

source Real figures were calculated with inflation data from:

TÜİK — Türkiye İstatistik Kurumu · TÜFE Genel Endeks (2003=100)

Türkiye Cumhuriyet Merkez Bankası (TCMB) — EVDS · evds3.tcmb.gov.tr

Fundamental & Technical Analysis
Profitability
Net Profit Margin %5.1
Net profit margin %5.1 — positive but low. Compared to previous quarter +4.6 point increase.
ROE - Return on Equity (TTM) %5.1
ROE %5.1 — low return on equity.
EBITDA Margin %12.1
EBITDA margin %12.1 — moderate operational efficiency.
Gross Profit Margin %12.1
Gross profit per revenue %12.1. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %2.3
TTM Free Cash Flow is %2.3'i. Moderate FCF — capex constraining operational profit.
Valuation
P/E Ratio 51.9x Sector: 28.4x
F/K 51.9x — sector median's (28.4x) %83 above. Expensive zone.
P/B Ratio 2.70x Sector: 2.87x
PD/DD 2.70x — sector median (2.87x) below or near. Reasonable valuation.
EV/EBITDA 12.7x Sector: 9.4x
EV/EBITDA 12.7x — sector median's (9.4x) %34 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 1.00x
Current ratio 1.00x — short-term liabilities exceed current assets. Liquidity risk.
Net Debt / EBITDA 4.0x
Net Debt/EBITDA 4.0x — high debt burden. Debt service creating pressure.
Debt / Equity 1.23x
Debt/Equity 1.23x — moderate financial leverage.
Interest Coverage 0.8x
Interest coverage 0.8x — critical level. Risk of difficulty in interest payments.
Growth
Revenue Growth (YoY) %+49.1
Revenue YoY %49.1 grew (2026/6) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %-41.9
Net profit YoY %-41.9 declined (2026/6) — serious profit erosion.
Score Explanations
Lothien Robustness
-
Weak robustness (38/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Potential
-
Plus %5.6 expected value (44.72) vs current price comparison. 3/4 valuation models could be calculated. Model confidence %59.
Components: PE target: 59.62 | P/B target: 45.24 | EV/EBITDA target: 31.60
Damodaran Valuation
-
Low Damodaran score (35/100). ROIC (%7.5) below cost of capital. DCF analysis does not support current price.
Weak
Dalio Risk Analysis
-
High debt risk (41/100). Interest coverage ratio 0.8x — weak, fragile. Debt/EBITDA 4.0x — manageable.
Leverage: 60/100 | Debt Service: 35/100 | Quality: 57/100
ROIC - Return on Capital
%7.5
ROIC (%7.5) cost of capital (36.7%) below → destroying value.
WACC: %36.7
Debt Cycle Phase
Contraction
High debt service + falling revenues. Balance sheet under pressure.
Piotroski F-Score
—
Graham Intrinsic Value
—
⚖️ Sector Comparison
P/E Ratio
51.9x vs 28.4x
Sector median's %83 above — expensive
P/B Ratio
2.70x vs 2.87x
Compared to sector %6 cheaper (by book value)
EV/EBITDA
12.7x vs 9.4x
Compared to sector %34 higher EV/EBITDA
ROIC vs WACC
%7.5 vs %36.7 WACC
ROIC 29.2 bps below cost of capital
Net Profit Margin (TTM)
%5.0 vs %13.5 EBITDA margin
TTM net profit margin %5.0
↔
TRAMA-99 Trend — Near TRAMA
Price (42.34), TRAMA-99 line (42.34) at close levels (%+0.0). Important decision zone — breakout direction will determine the trend.
Price:: 42.34
TRAMA: 42.34
Difference: %+0.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ KAP alım · ▼ KAP satım · ◆ KAP bildirim — KAP açıklamaları (içsel bilgi / pay-alım-satım / önemli-pay sahipliği); resmî bildirim, gün-içi gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?
Real vs Nominal Net Profit (CPI Adjusted) ?
Real vs Nominal Revenue (CPI Adjusted) ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

KARCL — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.